Physiomics (PYC)


Latest News

Physiomics turnover up 26%

Physiomics reports an operating loss of 431,561 for the year to the end of June - up from 414,755 in 2015. Turnover increased...

Final Results for the year ended 30 June 2016

RNS Number: 6529N Physiomics PLC 27 October 2016 27 October 2016 Physiomics Plc ("Physiomics" or "the Company") Final Results for the year ended 30 June 2016 Chairman's Statement Summary of Results in the year ended 30 June 2016 The turnover of the Company increased 26% to 297,120 (2015: 235,486) The loss after net operating expenses (excluding share-b...

Presentation at Conference on Pharmacometrics

RNS Number: 4250N Physiomics PLC 26 October 2016 Physiomics plc ("Physiomics") or ("the Company") Physiomics to give an oral presentation on developments of the Virtual Tumour platform in drug resistance at the Seventh American Conference on Pharmacometrics ("ACoP7") Physiomics plc (AIM: PYC), the Oxford, UK based systems biology Company, is p...

Physiomics notes directorate change

Physiomics said non-executive director Mark Chadwick will be leaving the company today, having served for six months ...

All News

27-10-16Physiomics turnover up 26%StockMarketWire
27-10-16Final Results for the year ended 30 June 2016RNS
26-10-16Presentation at Conference on PharmacometricsRNS
25-10-16Physiomics notes directorate changeStockMarketWire
25-10-16Directorate ChangeRNS
28-09-16Advisor ChangesRNS
21-09-16Physiomics updates on placing, acquisitionStockMarketWire
21-09-16Placing and Update on AcquisitionRNS
07-09-16Physiomics passes all AGM resolutionsStockMarketWire
07-09-16Result of GMRNS
22-08-16Notice of General MeetingRNS
18-08-16Physiomics inks SPA with BioMotiStockMarketWire
18-08-16Signing of Share Purchase Agreement with BioMotiRNS
16-08-16Physiomics appoints joint broker StockMarketWire
16-08-16Advisor ChangesRNS
16-05-16Physiomics extends Virtual Tumour Project StockMarketWire
16-05-16Extensions for Virtual Tumour ProjectRNS
03-05-16Appointment of part-time Head of FinanceRNS
18-04-16Physiomics appoints new CEOStockMarketWire
18-04-16Physiomics Appoints New Chief Executive OfficerRNS
06-04-16Physiomics to present at AACRStockMarketWire
06-04-16Virtual Tumour Developments Presentation at AACRRNS
04-04-16Physiomics extends contract with pharma companyStockMarketWire
04-04-16New Speciality Pharma Customer for new IndicationRNS
31-03-16FTSE falls on financals after UK current accountStockMarketWire
31-03-16Physiomics' lossStockMarketWire
31-03-16FTSE shies from highs as profiteers hit resourcesStockMarketWire
31-03-16Interim Results StatementRNS
31-03-16Heads of Terms with BioMoti and Board ChangesRNS
22-12-15Issue of OptionsRNS
22-12-15PYC in new contract with speciality pharma customerStockMarketWire
22-12-15New Speciality Pharma Customer for New IndicationRNS
14-12-15Result of General MeetingRNS
04-12-15Physiomics passes AGM resolutionsStockMarketWire
04-12-15Result of AGMRNS
27-11-15Notice of General MeetingRNS
10-11-15Final ResultsRNS
06-11-15Physiomics identifies potential acquisition targetStockMarketWire
06-11-15Strategic UpdateRNS

RSS feeds

  • Editorial news feed for LSE:PYC Editorial
  • Regulatory news feed for LSE:PYC Regulatory